Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy?

Journal of Neuro-Ophthalmology

Volumn 30, Issue 2, 2010, Pages 193-198

  Lee, Andrew G ^a   Biousse, Valérie ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; PREDNISONE; STEROID; TRIAMCINOLONE ACETONIDE;

ANTICOAGULATION; ARTERIAL INSUFFICIENCY; BRAIN ISCHEMIA; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; COMPARTMENT SYNDROME; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HYPERTENSION; INFECTION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; MONOCULAR VISION; NERVE DECOMPRESSION; NERVE SHEATH; NEUROOPHTHALMOLOGY; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; OPTIC NERVE; OPTIC NERVE DISEASE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PAPILLEDEMA; PATHOPHYSIOLOGY; PEPTIC ULCER; PERIMETRY; PRESCRIPTION; PRIORITY JOURNAL; RETINA MACULA EDEMA; REVIEW; RISK FACTOR; STEROID THERAPY; THROMBOSIS; TRAUMATIC BRAIN INJURY; VALIDITY; VASCULAR DISEASE; VISUAL ACUITY;

BLOOD-BRAIN BARRIER; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HUMANS; OPTIC NEUROPATHY, ISCHEMIC; OUTCOME ASSESSMENT (HEALTH CARE); PAPILLEDEMA; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STEROIDS; TREATMENT OUTCOME;

EID: 77953623927     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e3181e1f71f     Document Type: Review

References (31)

1. Foulds WS. Visual disturbances in systemic disorders: optic neuropathy and systemic disease. Trans Ophthalmol Soc U K. 1970;89:125-146.
2. Sanders MD. Ischaemic papillopathy. Trans Ophthalmol Soc U K. 1971;91:369-386.
3. Hayreh SS. Anterior ischemic optic neuropathy. III. Treatment, prophylaxis and differential diagnosis. Br J Ophthalmol. 1974;58:981-989.
4. Hayreh SS, Zimmerman MB. Optic disc edema in nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245:1107-1121.
5. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008;246: 1029-1046.
6. Atkins EA, Bruce BB, Newman NJ, Biousse V. Translation of clinical studies to clinical practice: survey on the treatment of nonarteritic anterior optic neuropathy. Am J Ophthalmol. 2009;148:809.
7. Atkins EA, Newman NJ, Biousse V. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2010;55:47-63.
8. Kaderli B, Avci R, Yucel A, Guler K, Gelisken O. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2007;27:164-168.
9. Yaman A, Selver OB, Saatci AO, Soylev MF. Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischemic optic neuropathy. Clin Exp Optom. 2008; 91:561-564.
10. Sohn BJ, Chun BY, Kwon JY. The effect of an intravitreal triamcinolone acetonide injection for acute nonarteritic anterior ischemic optic neuropathy. Korean J Ophthalmol. 2009;23:59-61.
11. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23:157-163.
12. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc. 2000;98:203-222.
13. Lessell S. Nonarteritic anterior ischemic optic neuropathy: enigma variations. Arch Ophthalmol. 1999;117:386-388.
14. McLeod D, Marshall J, Kohner EM. Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol. 1980;64:247-261.
15. Levin LA, Danesh-Meyer HV. Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2008;126:1582-1585.
16. Onda E, Cioffi GA, Bacon DR, Van Buskirk EM. Microvasculature of the human optic nerve. Am J Ophthalmol. 1995;120:92-102.
17. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke. 2007;38:1655-1711. (Pubitemid 46691097)
18. Canhao P, Cortesao A, Cabral M, Ferro JM, Stam J, Bousser MG, Barinagarrementeria F. For the ISCVT Investigators. Are steroids useful to treat cerebral venous thrombosis? Stroke. 2008;39:105-110.
19. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;118: 766-780.
20. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy: a case-control study of potential risk factors. Arch Ophthalmol. 1997;115: 1403-1407.
21. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with non-arteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial. Arch Ophthalmol. 1996;114:1366-1374.
22. Levin LA. Axonal loss and neuroprotection in optic neuropathies. Can J Ophthalmol. 2007;42:403-408.
23. Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol. 2009;147:11-21.
24. Hedges TR III, Vuong LN, Gonzalez-Garcia AO, Mendoza- Santiesteban CE, Amaro-Quierza ML. Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography. Arch Ophthalmol. 2008;126: 812-815.
25. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology. 1987;94:1503-1508.
26. Burde RM. Optic disc risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1993;116: 759-764.
27. Hayreh SS, Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2008;28:77-78.
28. Jonas JB, Spandau UH, Harder B, Sauder G. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245:749-750.
29. Kelman SE. Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study? J Neuroophthalmol. 2007;27:161-163.
30. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA. 1995;273: 625-632.
31. Biousse V, Calvetti O, Drews-Botsch CD, Atkins EJ, Sathornsumetee B, Newman NJ; Optic Neuritis Survey Group. Management of optic neuritis and impact of clinical trials: an international survey. J Neurol Sci. 2009;276: 69-74.